4-butyrolactone has been researched along with Spinal Cord Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, D; Shen, J; Xiao, W; Xu, Z; Yu, A | 1 |
1 other study(ies) available for 4-butyrolactone and Spinal Cord Injuries
| Article | Year |
|---|---|
Ligustilide treatment promotes functional recovery in a rat model of spinal cord injury via preventing ROS production.
Topics: 4-Butyrolactone; Angelica sinensis; Animals; Disease Models, Animal; Drugs, Chinese Herbal; Male; Neuroprotective Agents; Phytotherapy; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Recovery of Function; Spinal Cord Injuries | 2015 |